PMDA Review Report: Pfizer Vaccine’s Efficacy for Variants Not Gauged in Clinical Trials, Continued Info Collection Needed

The Pharmaceuticals and Medical Devices Agency (PMDA) released its review report for Pfizer/BioNTech’s COVID-19 vaccine on February 15, just a day after the product was granted fast-track approval under the name of Comirnaty. In its review report, the PMDA concluded...read more